ChemSpider 2D Image | Trimebutine Maleate | C26H33NO9

Trimebutine Maleate

  • Molecular FormulaC26H33NO9
  • Average mass503.542 Da
  • Monoisotopic mass503.215546 Da
  • ChemSpider ID4445578

  • Double-bond stereo - Double-bond stereo

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(1-Ethyl-1-phenyl-2-(3,4,5-trimethoxybenzoyloxy)ethyl)dimethylammonium hydrogen maleate
(2Z)-2-Butendisäure --2-(dimethylamino)-2-phenylbutyl-3,4,5-trimethoxybenzoat (1:1) [German] [ACD/IUPAC Name]
2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate (2Z)-2-butenedioate (1:1) [ACD/IUPAC Name]
2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate (2Z)-but-2-enedioate (1:1)
251-845-9 [EINECS]
2A051GM4YM
3,4,5-trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester maleate
3,4,5-Trimethoxybenzoic acid 2-(dimethylamino)-2-phenylbutyl ester maleate salt
34140-59-5 [RN]
58997-91-4 [RN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

D01500 [DBID]
MLS000028659 [DBID]
SMR000058893 [DBID]
T6284_SIGMA [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Bio Activity:

      GPCR/G protein MedChem Express HY-B0380A
      GPCR/G protein; Neuronal Signaling; MedChem Express HY-B0380A
      Opioid Receptor MedChem Express HY-B0380A
      Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects. MedChem Express
      Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.; Target: Opioid Receptor; Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. MedChem Express HY-B0380A
      Trimebutine maleate is a drug with antimuscarinic and weak mu opioid agonist effects.;Target: Opioid Receptor;Trimebutine is an agonist of peripheral mu, kappa and delta opiate receptors, used as spasmolytic agent for treatment of both acute and chronic abdominal pain [1]. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract [2, 3]. MedChem Express HY-B0380A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement